![](/img/cover-not-exists.png)
P413 A simple scoring tool predicts exposure–response relationship, onset of action, response to interval shortening, and surgical risk with vedolizumab therapy for Crohn’s disease
Dulai, P S, Amiot, A, Peyrin-Biroulet, L, Singh, S, Serrero, M, Jairath, V, Filippi, J, Pariente, B, Loftus Jr, E V, Roblin, X, Kane, S, Buisson, A, Siegel, C A, Bouhnik, Y, Sandborn, W J, Lasch, K, RVolume:
13
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjy222.537
Date:
January, 2019
File:
PDF, 89 KB
2019